Cannara Biotech Inc.
LOVFF
$0.926
-$0.0321-3.35%
OTC PK
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.92% | 7.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.92% | 7.84% | |||
| Cost of Revenue | -5.56% | 17.81% | |||
| Gross Profit | 12.99% | -4.16% | |||
| SG&A Expenses | -1.56% | 7.90% | |||
| Depreciation & Amortization | -3.58% | -44.17% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.46% | 12.77% | |||
| Operating Income | 34.24% | -11.72% | |||
| Income Before Tax | 49.85% | -20.52% | |||
| Income Tax Expenses | 86.81% | 137.08% | |||
| Earnings from Continuing Operations | 38.18% | -60.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.18% | -60.11% | |||
| EBIT | 34.24% | -11.72% | |||
| EBITDA | 25.51% | -12.11% | |||
| EPS Basic | 37.63% | -60.17% | |||
| Normalized Basic EPS | 49.67% | -11.05% | |||
| EPS Diluted | 37.63% | -57.53% | |||
| Normalized Diluted EPS | 49.01% | -10.65% | |||
| Average Basic Shares Outstanding | 0.60% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.74% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||